Ziwei Zeng

1.3k total citations · 2 hit papers
50 papers, 811 citations indexed

About

Ziwei Zeng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ziwei Zeng has authored 50 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Ziwei Zeng's work include Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (13 papers) and Colorectal Cancer Screening and Detection (11 papers). Ziwei Zeng is often cited by papers focused on Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (13 papers) and Colorectal Cancer Screening and Detection (11 papers). Ziwei Zeng collaborates with scholars based in China, Germany and United States. Ziwei Zeng's co-authors include Liang Kang, Huashan Liu, Zhenxing Liang, Xiaobin Zheng, Chi Zhou, Haiqing Jie, Ping Lan, Xianrui Wu, Xiaowen He and Shujuan Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Journal of Power Sources.

In The Last Decade

Ziwei Zeng

47 papers receiving 805 citations

Hit Papers

A Positive Feedback Loop between Inactive VHL-Triggered H... 2022 2026 2023 2024 2022 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Zeng China 14 434 271 235 125 107 50 811
Tao Ma China 11 434 1.0× 197 0.7× 206 0.9× 85 0.7× 70 0.7× 46 787
Margherita Cerrone Italy 14 322 0.7× 247 0.9× 266 1.1× 111 0.9× 60 0.6× 32 627
Claire Josse Belgium 20 590 1.4× 438 1.6× 137 0.6× 120 1.0× 104 1.0× 39 1.0k
Marc Guiu Spain 14 454 1.0× 228 0.8× 353 1.5× 119 1.0× 47 0.4× 20 848
Xiao Sun China 16 398 0.9× 240 0.9× 145 0.6× 94 0.8× 44 0.4× 40 795
Jang‐Seong Kim South Korea 14 337 0.8× 179 0.7× 132 0.6× 92 0.7× 119 1.1× 27 662
Kai Yin China 20 546 1.3× 411 1.5× 230 1.0× 183 1.5× 207 1.9× 54 1.1k
Xiufeng Hu China 15 522 1.2× 333 1.2× 214 0.9× 139 1.1× 72 0.7× 23 807
Qingxiang Zeng China 9 337 0.8× 233 0.9× 344 1.5× 174 1.4× 63 0.6× 18 768

Countries citing papers authored by Ziwei Zeng

Since Specialization
Citations

This map shows the geographic impact of Ziwei Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Zeng more than expected).

Fields of papers citing papers by Ziwei Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Zeng. The network helps show where Ziwei Zeng may publish in the future.

Co-authorship network of co-authors of Ziwei Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Zeng. A scholar is included among the top collaborators of Ziwei Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Zeng. Ziwei Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Li, Huashan Liu, Xianrui Wu, et al.. (2025). Glutamic-pyruvic transaminase 1 deficiency–mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression. Science Translational Medicine. 17(779). eadp9805–eadp9805. 3 indexed citations
2.
3.
Liang, Wenfeng, Haiqing Jie, Liang Huang, et al.. (2024). High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer. Clinical & Translational Immunology. 13(3). e1495–e1495. 1 indexed citations
4.
Li, Wenxin, Xianrui Wu, Sijing Cheng, et al.. (2024). Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. Nature Communications. 15(1). 499–499. 62 indexed citations breakdown →
5.
Zeng, Ziwei, Yujie Hou, Yonghua Cai, et al.. (2024). Effects of tumour budding on adjuvant chemotherapy in colorectal cancer. BJS Open. 8(1). 2 indexed citations
6.
Chen, Di, et al.. (2023). Serendipitous discovery of Class I HDAC inhibitors from rational design of molecular glue degraders targeting HDAC. European Journal of Medicinal Chemistry. 263. 115926–115926. 3 indexed citations
7.
Liu, Huashan, Ziwei Zeng, Zhenxing Liang, et al.. (2023). KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2–CXCL10 Axis in Colorectal Cancer. Cancer Immunology Research. 11(7). 875–894. 52 indexed citations
8.
Li, Lin, et al.. (2023). Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection. Journal of Personalized Medicine. 13(6). 990–990. 1 indexed citations
9.
Gong, Yingying, Huashan Liu, Liang Huang, et al.. (2023). circGlis3 promotes β-cell dysfunction by binding to heterogeneous nuclear ribonucleoprotein F and encoding Glis3-348aa protein. iScience. 27(1). 108680–108680. 4 indexed citations
10.
Li, Sheng, Lei Ruan, Zilin Chen, et al.. (2022). Engulfment and cell motility protein 1 fosters reprogramming of tumor‐associated macrophages in colorectal cancer. Cancer Science. 114(2). 410–422. 5 indexed citations
11.
Wang, Zhaohui, Ziwei Zeng, Vytaute Starkuviene, et al.. (2022). MicroRNAs Influence the Migratory Ability of Human Umbilical Vein Endothelial Cells. Genes. 13(4). 640–640. 5 indexed citations
12.
Hou, Yujie, Xingwei Zhang, Haiqing Jie, et al.. (2022). Transanal versus Laparoscopic Total Mesorectal Excision in Male Patients with Low Tumor Location after Neoadjuvant Therapy: A Propensity Score-Matched Cohort Study. Gastroenterology Research and Practice. 2022. 1–10. 8 indexed citations
13.
Zeng, Ziwei, Zhihang Liu, Shuangling Luo, et al.. (2021). Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Surgical Endoscopy. 36(6). 3902–3910. 11 indexed citations
14.
Liu, Huashan, Zhenxing Liang, Chi Zhou, et al.. (2021). Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer. Signal Transduction and Targeted Therapy. 6(1). 144–144. 61 indexed citations
15.
Huang, Liang, Xingwei Zhang, Yonghua Cai, et al.. (2021). Distinct Genomic Landscape of Colorectal Mucinous Carcinoma Determined via Comprehensive Genomic Profiling: Steps to a New Treatment Strategy. Frontiers in Oncology. 11. 603564–603564. 4 indexed citations
16.
Hua, Timothy, Julie Bejoy, Liqing Song, et al.. (2020). Cerebellar Differentiation from Human Stem Cells Through Retinoid, Wnt, and Sonic Hedgehog Pathways. Tissue Engineering Part A. 27(13-14). 881–893. 19 indexed citations
17.
Huang, Liang, et al.. (2020). Pure transanal endoscopic colectomy for ascending colon cancer. Techniques in Coloproctology. 24(11). 1207–1211.
18.
Zeng, Ziwei, Xianrui Wu, Junji Chen, et al.. (2019). Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum. Gastroenterology Research and Practice. 2019. 1–8. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026